Point of Care Diagnostics Market to Exhibit a Decent CAGR of 7.3% and Hit USD 23.36 Billion by 2027; Increasing Cases of Acute Diseases to Spur Sales Opportunities, states Fortune Business Insights™

NEXT STORY
VA San Diego Healthcare System Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients
PREV STORY
Skylight Health to Add 16th State with Acquisition of Florida Clinic Group with $5 million in Revenue and $1.2 million EBITDA
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athersys Reports Third Quarter 2018 Results

Management to host conference call at 4:30pm EST today CLEVELAND, Nov. 06, 2018 (GLOBE ...

author_avatar
NASDAQ Market News

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

author_avatar
NASDAQ Market News

Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis

author_avatar
NASDAQ Market News